Log In Sign Up

Unlisted Shares

IPO & Startups

Mutual Funds

PMS

Listed

Analyse

Track

  • Home
  • /
  • Triochem Products
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Company

Listed · BSE

Triochem Products

Pharmaceuticals & Drugs · Founded 1972 · www.trichemproducts.com · BSE 512101 · · ISIN INE331E01013

₹17.4 17.4 0%
Updated 00:00 IST
Watchlist Add to Bucket Notes Price Alert
Consolidated Standalone

My Notes

No Notes Added Yet

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
-
Stock P/E
—
P/B
—
Current Price
₹17.4
Book Value
₹ 0
Face Value
10
52W High
—
52W Low
—
Dividend Yield
—
Edit Ratio

Triochem Products Share Price

Live · BSE · Inception: 1972
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Triochem Products Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0 0 0 0 0 0 0 0 0 0
Other Income 1 0 0 0 0 0 0 0 0 0
Total Income 1 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 1 0 0 0 0 0 0
Operating Profit 0 -0 -0 -0 -0 -0 -0 -0 -0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 11 0
Profit Before Tax 0 -0 -0 -0 -0 -0 -0 -0 11 0
Provision for Tax 0 -0 -0 -0 0 -0 0 -0 3 0
Profit After Tax 0 -0 -0 0 -0 -0 -0 -0 8 0
Adjustments 0 0 -0 0 0 -0 0 -0 -0 0
Profit After Adjustments 0 -0 -0 0 -0 -0 -0 -0 8 0
Adjusted Earnings Per Share 13.2 -3.2 -1.5 3.6 -18.4 -1.2 -7.9 -5.3 339.9 3.9

Triochem Products Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 23 18 35 12 20 14 9 0 0 0 0 0
Other Income 0 0 0 0 0 0 1 0 1 1 1 0
Total Income 23 18 35 12 20 14 9 0 1 1 1 0
Total Expenditure 22 17 31 11 16 14 7 1 1 1 1 0
Operating Profit 1 1 4 2 5 -0 2 -1 -0 -0 -0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 -1 0 11 11
Profit Before Tax 1 1 4 1 5 -1 2 -1 -1 -0 11 11
Provision for Tax 0 0 1 0 1 -0 0 -0 -0 0 3 3
Profit After Tax 0 1 3 1 3 -0 1 -1 -1 -0 8 8
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 1 3 1 3 -0 1 -1 -1 -0 8 8
Adjusted Earnings Per Share 13.9 23.9 104.3 30.3 138.9 -18.2 54 -36.1 -41.4 -16.3 325.3 330.6

Triochem Products Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 5 5 8 9 12 12 13 12 15 14 21
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 -0 0 -0 -0 -0 0
Total Current Liabilities 2 5 4 6 4 0 0 0 0 0 0
Total Liabilities 7 10 12 15 17 12 13 12 15 14 21
Fixed Assets 2 2 1 1 1 1 1 1 1 1 0
Other Non-Current Assets 4 0 1 0 0 0 0 10 11 11 8
Total Current Assets 1 8 10 14 15 11 12 1 3 3 13
Total Assets 7 10 12 15 17 12 13 12 15 14 21

Triochem Products Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1 0 0 1 0 1 8 12 1 1 1
Cash Flow from Operating Activities 7 -6 1 -4 4 10 3 -1 -4 0 -3
Cash Flow from Investing Activities -4 4 -0 0 -0 0 0 -10 3 0 14
Cash Flow from Financing Activities -4 3 -1 3 -3 -3 -0 0 0 0 0
Net Cash Inflow / Outflow -1 0 1 -1 0 8 4 -11 -0 0 11
Closing Cash & Cash Equivalent 0 0 1 0 1 8 12 1 1 1 12

Triochem Products Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 13.94 23.93 104.29 30.32 138.89 -18.24 53.99 -36.13 -41.36 -16.33 325.33
CEPS(Rs) 24.96 35.22 114.38 38.71 145.7 -12.58 58.86 -31.84 -37.7 -13.19 327.24
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 199.76 223.69 327.86 358.19 497 478.04 532.51 473.36 596.74 557.83 842.78
Core EBITDA Margin(%) 4.01 5.44 10.71 13.35 22.59 -2.66 15.16 0 0 0 0
EBIT Margin(%) 2.99 4.85 11.17 12.14 24.09 -2.7 20.21 0 0 0 0
Pre Tax Margin(%) 2.15 4.47 10.05 8.41 22.72 -4.17 19.99 0 0 0 0
PAT Margin (%) 1.42 3.19 7.19 6.01 16.99 -3.21 15 0 0 0 0
Cash Profit Margin (%) 2.54 4.69 7.89 7.68 17.82 -2.21 16.35 0 0 0 0
ROA(%) 4.41 6.78 23.15 5.51 21.42 -3.12 10.42 -7.11 -7.75 -2.81 45.9
ROE(%) 7.23 11.3 37.82 8.84 32.48 -3.74 10.69 -7.18 -7.73 -2.83 46.46
ROCE(%) 11.1 13.48 42.55 12.05 32.99 -2.85 14.4 -9.48 -10.14 -1.73 61.9
Receivable days 0 48.54 0 98.38 143.3 180.55 0 0 0 0 0
Inventory Days 34.53 25.1 53.53 262.93 101.39 31.52 18.76 0 0 0 0
Payable days 16.54 41.4 15.18 23.27 14.55 15.44 14.36 0 0 1176.98 0
PER(x) 0 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) -0.01 0.15 0.05 0.47 0.11 -0.57 -1.31 0 0 0 0
EV/Core EBITDA(x) -0.12 2.31 0.38 3.4 0.44 33.55 -6.08 0.67 3.55 3.93 22.99
Net Sales Growth(%) -24.66 -21.85 93.73 -64.69 62.14 -30.42 -36.71 -100 0 0 0
EBIT Growth(%) -28.33 24.06 344.93 -62.2 221.74 -107.79 574.37 -165.54 -13.72 81.56 4434.82
PAT Growth(%) -17.88 71.63 335.8 -70.92 358.06 -113.14 395.93 -166.91 -14.48 60.53 2092.68
EPS Growth(%) -17.88 71.63 335.8 -70.92 358.06 -113.14 395.93 -166.91 -14.48 60.53 2092.68
Debt/Equity(x) 0 0.52 0.28 0.66 0.21 0 0 0 0 0 0
Current Ratio(x) 0.55 1.76 2.74 2.21 3.54 28.2 56.63 5.38 10.24 11.27 417.71
Quick Ratio(x) 0.37 1.29 0.47 0.68 3.18 26.01 56.38 5.16 10.05 11.27 417.71
Interest Cover(x) 3.55 12.65 9.98 3.26 17.68 -1.83 91.42 -778.93 -1022.08 -222.73 103.82
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR — — -100% -100%
Operating Profit CAGR — — — -100%
PAT CAGR — — — —
Share Price CAGR — — — 0%
ROE Average +46% +12% +8% +12%
ROCE Average +62% +17% +11% +15%

Triochem Products Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 68.65 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 31.35 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 68.6568.6568.6568.6568.6568.6568.6568.6568.6568.65
FII 0000000000
DII 0000000000
Public 31.3531.3531.3531.3531.3531.3531.3531.3531.3531.35
Others 0000000000
Total 100100100100100100100100100100

Triochem Products Peer Comparison

Pharmaceuticals & Drugs Edit Columns
Open Pharmaceuticals & Drugs industry page ›

Triochem Products Quarterly Price

10-year quarterly close · BSE
Quarterly Monthly
Show Value Show %

News & Updates

See more…

Triochem Products Pros & Cons

Auto-generated · Sharescart Insights

Pros

  • Debtor days have improved from 1176.98 to 0days.

Cons

  • Company has a low return on equity of 12% over the last 3 years.
  • Earnings include an other income of Rs. 1 Cr.

* The pros and cons are machine generated.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Explore More

You may also know about

Unlisted Shares

Private & pre-listed companies

Pre-IPO Shares

Invest before the listing

ESOP Shares

Employee stock options

Delisted Shares

Companies no longer on exchanges
whatsapp

Error!

View quotes